These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 4866642

  • 1. Ocular damage in chloroquine therapy.
    Nylander U.
    Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
    [No Abstract] [Full Text] [Related]

  • 2. Ocular damage in chloroquine therapy.
    Nylander U.
    Acta Ophthalmol (Copenh); 1966; 44(3):335-48. PubMed ID: 5953229
    [No Abstract] [Full Text] [Related]

  • 3. [On ocular damage caused by chloroquine].
    Rinaldi G, Coslovich E, Tuvo F.
    Minerva Med; 1971 Feb 24; 62(16):766-9. PubMed ID: 5313741
    [No Abstract] [Full Text] [Related]

  • 4. Chloroquine: ophthalmological safety, and clinical assessment in rheumatoid arthritis.
    Percival SP, Meanock I.
    Br Med J; 1968 Sep 07; 3(5618):579-84. PubMed ID: 4875645
    [Abstract] [Full Text] [Related]

  • 5. [Chloroquine retinopathy].
    François J, de Rouck A, Cambie E, de Laey JJ.
    Ophthalmologica; 1972 Sep 07; 165(2):81-99. PubMed ID: 4539289
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acquired color vision defects secondary to retinal drug toxicity.
    Grützner P.
    Ophthalmologica; 1969 Sep 07; 158 Suppl():592-604. PubMed ID: 5307973
    [No Abstract] [Full Text] [Related]

  • 9. [Supervision of the eyes during prolonged treatment with synthetic antimalarial drugs. Results in 237 patients followed up for 4 years on the average].
    Bertrand JJ, Debeyre N, Kahn MF, Ryckewaert A.
    Presse Med (1893); 1968 Nov 23; 76(45):2139-42. PubMed ID: 5720115
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ocular toxicity of antimalarial drugs. Long-term follow-up.
    Carr RE, Henkind P, Rothfield N, Siegel IM.
    Am J Ophthalmol; 1968 Oct 23; 66(4):738-44. PubMed ID: 5729592
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Electroretinography in patients with connective tissue diseases treated with hydroxychloroquine.
    Sassaman FW, Cassidy JT, Alpern M, Maaseidvaag F.
    Am J Ophthalmol; 1970 Oct 23; 70(4):515-23. PubMed ID: 5505469
    [No Abstract] [Full Text] [Related]

  • 14. The multifocal pattern electroretinogram in chloroquine retinopathy.
    Neubauer AS, Stiefelmeyer S, Berninger T, Arden GB, Rudolph G.
    Ophthalmic Res; 2004 Oct 23; 36(2):106-13. PubMed ID: 15017107
    [Abstract] [Full Text] [Related]

  • 15. Keratopathy with low dose chloroquine therapy.
    Cullen AP, Chou BR.
    J Am Optom Assoc; 1986 May 23; 57(5):368-72. PubMed ID: 3711574
    [Abstract] [Full Text] [Related]

  • 16. Blue-yellow perimetry can be an early detector of hydroxychloroquine and chloroquine retinopathy.
    Razeghinejad MR, Torkaman F, Amini H.
    Med Hypotheses; 2005 May 23; 65(3):629-30. PubMed ID: 15949899
    [No Abstract] [Full Text] [Related]

  • 17. [Chloroquine and ocular disorders].
    Kimura R, Nagano S, Watanabe H, Okamura R.
    Seikei Geka; 1966 Jun 23; 17(6):468-73. PubMed ID: 6007161
    [No Abstract] [Full Text] [Related]

  • 18. [Chloroquine retinopathy. Peculiar behavior of the light sense].
    Stein R, Godel V, Nemet P.
    Klin Monbl Augenheilkd; 1972 Aug 23; 161(2):183-91. PubMed ID: 4638561
    [No Abstract] [Full Text] [Related]

  • 19. Chloroquine ocular toxicity.
    Bernstein HN.
    Surv Ophthalmol; 1967 Oct 23; 12(5):415-47. PubMed ID: 4980087
    [No Abstract] [Full Text] [Related]

  • 20. Pigmentation and retinopathy due to chloroquine.
    Stewart TW, Miles DW, Earnshaw ER.
    Acta Derm Venereol; 1968 Oct 23; 48(1):47-52. PubMed ID: 4174103
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.